Epidemiological and Clinical Features of Critical and Non-Critical Elderly COVID-19 Patients in Udayana University Academic Hospital: A Retrospective Study

C. Purnamasidhi, I. Somia, D. Júnior, R. Suteja, I. Adiputra, G. Purnama, I. Weisnawa, Jerry, P. Wulandari, D. Shanti, I. Diksha
{"title":"Epidemiological and Clinical Features of Critical and Non-Critical Elderly COVID-19 Patients in Udayana University Academic Hospital: A Retrospective Study","authors":"C. Purnamasidhi, I. Somia, D. Júnior, R. Suteja, I. Adiputra, G. Purnama, I. Weisnawa, Jerry, P. Wulandari, D. Shanti, I. Diksha","doi":"10.20473/ijtid.v11i1.43097","DOIUrl":null,"url":null,"abstract":"Elderly COVID-19 patients have been associated with worse outcomes and have been presented with the highest mortality rate. However, studies on the clinical features and the differences between critical and non-critical elderly COVID-19 patients in Indonesia and even other countries are still lacking and rare. In this retrospective study, the epidemiological and clinical features of critical and non-critical elderly COVID-19 patients admitted to Udayana University Academic Hospital between April 2020 and March 2021 were analyzed and then compared. Of the 280 medical records analyzed, 60.7% were male and the median age was 65.0 years old. Based on the medical records, 18.2% of elderly patients met our criteria of critical patients. The most common symptoms presented in both category upon admission included fever and coughing. The most common comorbidity found in critical patients was heart disease and hypertension in non-critical patients. Laboratory results differences included leukocytes, neutrophils, lymphocytes, Neutrophil-to-Lymphocyte Ratio, platelets, SGOT, SGPT, and urea. Only 9.9% of critical patients and 6.1% of non-critical patients were given antiviral therapy. In contrast, 68.6% of critical patients and 76% of non-critical patients were given antibiotics. The mortality rate in critical patients was 70.6% and 0.4% in non-critical patients. Based on the results, a multimodal approach in the treatment of elderly COVID-19 patients is very essential. The higher mortality rate in elderly patients should be able to be reduced by giving early and timely antiviral therapy with the addition of effective choice of drugs.","PeriodicalId":13538,"journal":{"name":"Indonesian Journal of Tropical and Infectious Disease","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indonesian Journal of Tropical and Infectious Disease","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.20473/ijtid.v11i1.43097","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Elderly COVID-19 patients have been associated with worse outcomes and have been presented with the highest mortality rate. However, studies on the clinical features and the differences between critical and non-critical elderly COVID-19 patients in Indonesia and even other countries are still lacking and rare. In this retrospective study, the epidemiological and clinical features of critical and non-critical elderly COVID-19 patients admitted to Udayana University Academic Hospital between April 2020 and March 2021 were analyzed and then compared. Of the 280 medical records analyzed, 60.7% were male and the median age was 65.0 years old. Based on the medical records, 18.2% of elderly patients met our criteria of critical patients. The most common symptoms presented in both category upon admission included fever and coughing. The most common comorbidity found in critical patients was heart disease and hypertension in non-critical patients. Laboratory results differences included leukocytes, neutrophils, lymphocytes, Neutrophil-to-Lymphocyte Ratio, platelets, SGOT, SGPT, and urea. Only 9.9% of critical patients and 6.1% of non-critical patients were given antiviral therapy. In contrast, 68.6% of critical patients and 76% of non-critical patients were given antibiotics. The mortality rate in critical patients was 70.6% and 0.4% in non-critical patients. Based on the results, a multimodal approach in the treatment of elderly COVID-19 patients is very essential. The higher mortality rate in elderly patients should be able to be reduced by giving early and timely antiviral therapy with the addition of effective choice of drugs.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
乌达亚那大学附属医院老年COVID-19危重与非危重患者流行病学及临床特征的回顾性研究
老年新冠肺炎患者的预后较差,死亡率最高。然而,关于印度尼西亚甚至其他国家危重和非危重老年新冠肺炎患者的临床特征和差异的研究仍然缺乏且罕见。在这项回顾性研究中,分析并比较了2020年4月至2021年3月期间Udayana大学学术医院收治的危重和非危重老年新冠肺炎患者的流行病学和临床特征。在分析的280份病历中,60.7%为男性,中位年龄为65.0岁。根据医疗记录,18.2%的老年患者符合我们的危重症患者标准。两类患者入院时最常见的症状包括发烧和咳嗽。危重患者最常见的合并症是心脏病和非危重患者的高血压。实验室结果差异包括白细胞、嗜中性粒细胞、淋巴细胞、中性粒细胞与淋巴细胞比率、血小板、SGOT、SGPT和尿素。只有9.9%的危重患者和6.1%的非危重患者接受了抗病毒治疗。相比之下,68.6%的危重症患者和76%的非危重症患者服用了抗生素。危重症患者的死亡率为70.6%,非危重症患者为0.4%。根据研究结果,多模式治疗老年新冠肺炎患者是非常必要的。老年患者较高的死亡率应该能够通过早期及时的抗病毒治疗和有效的药物选择来降低。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
8
审稿时长
12 weeks
期刊最新文献
Screening of Legionella pneumophila from Well Water in Magetan Regency, Indonesia Risk Factors Associated with Suspected Clostridium difficile Infection (CDI) in Elderly Diarrhea Patients at Prof. Dr. I.G.N.G. Ngoerah Hospital Examining convalescent plasma transfusion in severe COVID-19 patients, recent research highlights the significance of S-RBD antibodies and IL-10 levels Nigella sativa 3% Inhibition Test of Nаturаl Toothpаste Compаred Cetylpyridinum chloride (CPC) Toothpаste 0.01-0.1% on Аggregаtibаcter actinomycetemcomitаns Polysaccharide Capsule Serotype and Antibiotic Susceptibility Pattern of Streptococcus pneumoniae Clinical Isolates in Bali
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1